Literature DB >> 10436859

Mutations in the human 5-lipoxygenase gene.

K H In1, E S Silverman, K Asano, D Beier, A R Fischer, T P Keith, K Serino, C Yandava, G T De Sanctis, J M Drazen.   

Abstract

Our data demonstrate the presence of a naturally occurring family of alleles in the core promoter of the 5-LO gene, which is characterized by the deletion or addition of consensus Sp1 (-GGGCGG) and Egr-1 (-GCGGGGGCG-) binding motifs. Each of the variant alleles can bind Sp1 and Egr-1 protein, as indicated by EMSA and supershift analysis with nuclear extracts. In addition, preliminary data from CAT reporter assays indicate that these alleles are less effective than the wild-type allele in initiating 5-LO gene expression. Whether patients harboring the various alleles identified herein have different capacities to transcribe the 5-LO gene and the importance of such potential regulation to the clinical expression of 5-LO have yet to be determined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10436859     DOI: 10.1007/BF02737597

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  13 in total

Review 1.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects.

Authors:  B Samuelsson; S E Dahlén; J A Lindgren; C A Rouzer; C N Serhan
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

2.  Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group.

Authors:  M C Liu; L M Dubé; J Lancaster
Journal:  J Allergy Clin Immunol       Date:  1996-11       Impact factor: 10.793

3.  Interferon gamma regulates binding of two nuclear protein complexes in a macrophage cell line.

Authors:  P W Finn; C J Kara; J Douhan; T T Van; V Folsom; L H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  Characterization of the human 5-lipoxygenase gene.

Authors:  C D Funk; S Hoshiko; T Matsumoto; O Rdmark; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Randomized trial of zileuton in patients with moderate asthma: effect of reduced dosing frequency and amounts on pulmonary function and asthma symptoms. Zileuton Study Group.

Authors:  L M DuBuske; J Grossman; L M Dubé; L J Swanson; J F Lancaster
Journal:  Am J Manag Care       Date:  1997-04       Impact factor: 2.229

6.  Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.

Authors:  K H In; K Asano; D Beier; J Grobholz; P W Finn; E K Silverman; E S Silverman; T Collins; A R Fischer; T P Keith; K Serino; S W Kim; G T De Sanctis; C Yandava; A Pillari; P Rubin; J Kemp; E Israel; W Busse; D Ledford; J J Murray; A Segal; D Tinkleman; J M Drazen
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

7.  5-lipoxygenase inhibitory activity of zileuton.

Authors:  G W Carter; P R Young; D H Albert; J Bouska; R Dyer; R L Bell; J B Summers; D W Brooks
Journal:  J Pharmacol Exp Ther       Date:  1991-03       Impact factor: 4.030

8.  Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.

Authors:  T F Reiss; P Chervinsky; R J Dockhorn; S Shingo; B Seidenberg; T B Edwards
Journal:  Arch Intern Med       Date:  1998-06-08

9.  Clonal transformation of adult human leukocytes by Epstein-Barr virus.

Authors:  B Sugden; W Mark
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

10.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

Authors:  B Samuelsson
Journal:  Science       Date:  1983-05-06       Impact factor: 47.728

View more
  6 in total

1.  5-Lipoxygenase: mechanisms of regulation.

Authors:  Olof Rådmark; Bengt Samuelsson
Journal:  J Lipid Res       Date:  2008-11-05       Impact factor: 5.922

2.  Functional analysis of 5-lipoxygenase promoter repeat variants.

Authors:  Susanna Vikman; Romulo M Brena; Patrice Armstrong; Jaana Hartiala; Charles B Stephensen; Hooman Allayee
Journal:  Hum Mol Genet       Date:  2009-08-28       Impact factor: 6.150

3.  ALOX5 polymorphism associates with increased leukotriene production and reduced lung function and asthma control in children with poorly controlled asthma.

Authors:  E Mougey; J E Lang; H Allayee; W G Teague; A J Dozor; R A Wise; J J Lima
Journal:  Clin Exp Allergy       Date:  2013-05       Impact factor: 5.018

4.  Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma.

Authors:  Nathan Rabinovitch; David T Mauger; Nichole Reisdorph; Ronina Covar; Jonathan Malka; Robert F Lemanske; Wayne J Morgan; Theresa W Guilbert; Robert S Zeiger; Leonard B Bacharier; Stanley J Szefler
Journal:  J Allergy Clin Immunol       Date:  2013-09-29       Impact factor: 10.793

5.  Association of 5-lipoxygenase gene polymorphisms with bronchial asthma.

Authors:  Chunying Bai; Xiaoming Yu; Rui Yun; Tiewei Shi; Chaojun Zhang; Jing Zhou; Lijuan Tong; Xiujun Li; Lifeng Gao
Journal:  Exp Ther Med       Date:  2012-09-17       Impact factor: 2.447

6.  Dormant 5-lipoxygenase in inflammatory macrophages is triggered by exogenous arachidonic acid.

Authors:  Carlos A Sorgi; Simona Zarini; Sarah A Martin; Raphael L Sanchez; Rodrigo F Scandiuzzi; Miguel A Gijón; Carlos Guijas; Nicolas Flamand; Robert C Murphy; Lucia H Faccioli
Journal:  Sci Rep       Date:  2017-09-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.